Siemens Healthineers unveil revolutionary innovations in line with ambitious sustainability goals at Arab Health 2025
Siemens Healthineers to launch their latest photon-counting CT scanner and virtually helium-free Magnetic Resonance Imaging platform
Siemens Healthineers, the global leader in medical technology, is set to redefine medical imaging with the launch of a transformative computed tomography (CT) scanner powered by Quantum Technology and AI at Arab Health 2025 (January 27-30, Dubai World Trade Centre). The NAEOTOM® Alpha class highlights Siemens Healthineers' commitment to pioneering breakthroughs in healthcare for everyone, everywhere. Sustainably.
Vivek Kanade, Managing Director, Siemens Healthineers, Middle East and Africa said: 'At Siemens Healthineers, innovation is in our DNA and at the core of everything we do. We are continuously pushing the boundaries of medical technology to make diagnoses and treatments more accurate and timelier. From advanced imaging systems, human-centered laboratory designs and intelligent cancer care to AI-driven diagnostic tools, we are creating solutions that enable healthcare professionals to make quicker, more precise decisions. These innovations not only improve patient outcomes, but also help make healthcare more accessible, equitable, and faster, ultimately transforming the way care is delivered worldwide. At Arab Health 2025, we will take visitors on a patient-centric journey of how we believe the future of care delivery will look like'
Siemens Healthineers has made an unstoppable commitment to transform medical imaging with photon-counting CT, now presenting the NAEOTOM® Alpha class, three photon-counting CT systems that can support diagnostic results and processes in many clinical scenarios. Proven Quantum Technology enables profound clinical impact, supported by AI-powered productivity solutions.
The NAEOTOM® Alpha class delivers precise anatomical details with Quantum HD resolution with up to 0.2 mm, and Quantum Spectral imaging in every scan enables precise functional evaluation. Address limitations of conventional CT and experience the profound clinical impact of photon-counting CT.
Making its regional debut, Siemens Healthineers also introduces at Arab Health 2025 the MAGNETOM Flow. Platform, a next-generation 1.5T Magnetic Resonance Imaging (MRI) solution. Designed for sustainability by combining an independent magnet and low power consumption, enhancing patient comfort, contributing to greater workflow efficiency and shorter examination times. Patient well-being is pivotal to MRI examinations, promoting cooperation, more precise results and reducing the need for repeat examinations.
Adopting a patient-centric perspective, the Siemens Healthineers booth at Arab Health 2025 transforms into an immersive journey, mirroring clinical pathways in oncology, neurology, and cardiology that are navigated by healthcare providers and patients alike. It showcases how innovations in diagnostic imaging, laboratory diagnostics, and cancer therapy intersect to address the world's most pressing healthcare challenges, including cancer, stroke, and cardiovascular diseases.
Guided by its purpose — "We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably" – Siemens Healthineers' booth shows how it is addressing global healthcare challenges while advancing access, equity, and sustainability in the region. The booth will also take visitors on a digital journey through Siemens Healthineers' collaborations with public and private healthcare providers in the Middle East, underscoring their commitment to future-proofing local healthcare systems through digital transformation, automation, and value-driven solutions.
Additional highlights at Arab Health 2025
Visitors at the Siemens Healthineers booth will also receive hands-on experiences with solutions across key fields including:
Ultrasound: The ACUSON Sequoia 3.5, the industry's first abdominal scanning system with advanced AI, enables real-time organ labeling and measurements, streamlining workflows and delivering unparalleled precision.
Molecular Imaging: The Biograph Trinion PET/CT (positron emission tomography / computed tomography) scanner offers ultra-fast time-of-flight performance and exceptional small lesion detectability, ensuring accurate diagnostics with reduced radiation doses.
X-Ray Imaging: The LUMINOS Q.namix fluoroscopy platform and the MAMMOMAT B.brilliant mammography system introduce new dimensions in multifunctionality and patient-centric imaging.
Join Siemens Healthineers at Booth S1.C10 from January 27-30, at Arab Health 2025 to experience these innovations firsthand and glimpse the future of healthcare.
-Ends-
About Siemens Healthineers
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.
For more information, please contact:
Gambit Communications
Tony Sidgwick
Account Director
tony@gambit.ae
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TECHx
5 days ago
- TECHx
Check Point Launches Quantum Smart-1 Appliances
Home » Emerging technologies » Cyber Security » Check Point Launches Quantum Smart-1 Appliances Check Point® Software Technologies Ltd. (NASDAQ: CHKP) has announced the launch of its next-generation Quantum Smart-1 Management Appliances. The company is a global leader in cybersecurity solutions. The new appliances deliver a 2X increase in managed gateways. They also offer up to 70% higher log processing speeds. These improvements are designed to meet the complex demands of hybrid enterprises. Check Point revealed that the appliances are fully integrated into the Check Point Infinity Platform. This integration enhances threat detection and response using a hybrid mesh architecture. It also supports connections with over 250 third-party solutions. Nataly Kremer, Chief Product Officer at Check Point, stated that security teams are under pressure from AI-generated threats and fragmented infrastructures. She said the new appliances simplify these challenges through AI, automation, and precision. The rise of remote work and distributed teams has increased vulnerabilities. Check Point Research reported that AI services are now used in over 51% of enterprise networks each month. This growth widens security risks, making advanced security policies essential. According to Check Point, the Quantum Smart-1 Management Appliances help security teams operate faster and smarter across on-premises, cloud, and remote environments. Key features include: Managing up to 10,000 gateways, enabling scale without rearchitecting. Achieving up to 70% higher log speeds for faster threat response. Storing up to 70TB of logs locally to meet compliance needs. The appliances unify security operations and reduce complexity in hybrid environments. They are available in five models, including the high-performance 7000 Ultra. Check Point confirmed that the new models support tools like Infinity AI Copilot, Playblocks, Policy Advisor, Compliance, and Infinity AIOps. These tools streamline policy and firewall management. Miercom recently named Check Point the top performer in its AI-Powered Cyber Security Platform Benchmark. The report recognized Check Point's superior management usability and threat prevention. Rob Smithers, CEO of Miercom, said Check Point's Infinity Platform outperformed its peers. He added that its AI-driven design and hybrid mesh model set a new standard in cybersecurity. Check Point continues to advance cybersecurity with AI-powered solutions tailored for modern enterprise needs.
Al Etihad
5 days ago
- Al Etihad
M42, AstraZeneca, SOPHiA GENETICS to transform cancer diagnosis, care
3 June 2025 14:30 ABU DHABI (ALETIHAD)M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS®, powered with SOPHiA DDM™ technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood approach does not replace but rather complements routine cancer screenings, and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the new testing programme will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said, 'This collaboration reflects our vision of democratising health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalised care.'Sameh El Fangary, Cluster President GCC of AstraZeneca, stated, "Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimising patient pathways from detection to therapy.' Ross Muken, President of SOPHiA GENETICS, said, "Expanding access to advanced testing technologies is central to our mission at SOPHiA GENETICS. Partnering with M42 and AstraZeneca in the UAE allows us to equip healthcare providers with the tools they need to personalise care, monitor disease in real-time, and ultimately improve outcomes for patients across the region." Source: Aletihad - Abu Dhabi
Al Etihad
6 days ago
- Al Etihad
Pulse and hopes high when healthcare and Al hold hands
3 June 2025 01:00 EISSA ALI ALMANNEI *Technological progress sometimes affects human lives slightly and sometimes in profound ways. But when it empowers vital sectors like healthcare, the hopes pinned on this technological revolution increase. This is exactly the case with harnessing artificial intelligence in the healthcare industry and the adoption of AI tools by healthcare institutions to assist at every stage of the care language models, chatbots, and voice assistants are now integrated into AI-powered workflows across clinics and hospitals, helping in internal processes and medical records. AI can improve operations, from human resources to insurance claims, facilitating data management and applying AI tools to generate automated reports and resource utilisation metrics in real saves a lot of time on administrative tasks and interactions while reducing costs. AI is not limited to administrative and financial operations. In fact, it can give anonymous patient data, such as MRI scans, CT images, lab results, and clinical notes, to feed AI diagnostic radiology, AI helps doctors transcend the limitations of the human eye, as it trains algorithms to reconstruct blurry images and highlight areas of concern, such as tumors or fractures. With big data and patient record analysis, healthcare professionals can detect patterns and risk factors that might be missed in traditional diagnostic of the fundamental advantages of AI in healthcare is its ability to improve diagnostic accuracy and treatment plans, which enables faster decision-making by providing physicians with precise, real-time information. In emergencies, where time is critical to saving lives, AI-assisted robotics can improve surgical outcomes, aid surgeons in enhancing precision, reduce complications, and improve patient the pharmaceutical sector, companies rely on AI to analyse chemical composition databases, protein interactions, and side effects. This not only accelerates drug development but also increases the success rate of new medications while improving safety and reducing the risk of adverse reactions. AI can even predict individual responses to treatments by analysing genetic profiles and medical histories and discovering how a specific gene variant affects drug addition, AI can simulate patients in clinical training, allowing students to adapt to various cases. Virtual patients respond in real time to what the student says or does, creating a more realistic experience. AI is also being used in mental health, guiding cancer survivors through post-treatment care, and assisting in the early detection of diseases, including certain types of AI is still relatively new in healthcare, there is now a smart hospital in China operated by fourteen AI-powered virtual doctors who diagnose and treat patients without any human staff. This virtual team is capable of treating over 3,000 patients daily. This implies that AI's ability to match, or even exceed, human diagnostic capabilities in terms of accuracy and speed is within there are challenges related to the ambiguity of AI models to physicians, making it difficult to understand how they arrive at conclusions. This lack of clarity can confuse doctors when they cannot grasp the reasons behind an algorithm's there are concerns about protecting patients' medical privacy, as AI relies on massive datasets that frequently contain sensitive health information. AI outcomes can also be biased due to disparities or differences in training data, leading to distorted results. Therefore, the quality and balance of the data used to train these models are critical to ensuring accurate and reliable hopes for AI in healthcare are undeniable. Medical AI systems can process information faster than any human doctor, but caution is needed to address challenges, use data analysis and advanced analytics, and continue developing technologies that aid in disease diagnosis, prevention, personalised treatment, and drug development to improve the quality of human life. * The writer is a researcher at TRENDS Research & Advisory
